Sign in to view content

New Tool for Predicting the 3-Year Risk of Vision-Threatening Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus

Bobeck S Modjtahedi, MD

Video
Published 2022

Related

Protocol U: Short-Term Evaluation of Combination Dexamethasone + Ranibizumab vs. Ranibizumab Alone for Persistent Central-Involv
Raj K. Maturi, MD
Updates from the Field
2017
Predictive Modeling of Proliferative Diabetic Retinopathy and DME Based on Analysis of High-Value Biomarkers
Kameran Lashkari, MD, FASRS
On Demand Cases, Courses, and Papers
2019
Steroid vs. Anti-VEGF for Diabetic Macular Edema Prior to Phacoemulsification (STAMP)
Caesar K. Luo, MD, FASRS
On Demand Cases, Courses, and Papers
2021

Category: Diabetic Retinopathy

See more